Analisis Keuangan Saham ONC - BeOne Medicines AG - Depositary Receipt (Common Stock) (NasdaqGS) Stock

Gambaran Umum

BeiGene, Ltd. is a global biotechnology company based in China, primarily focused on the discovery, development, manufacturing, and commercialization of innovative molecularly targeted and immuno-oncological drugs for the treatment of cancer. Founded in 2010, the company has rapidly expanded its presence with additional offices in the United States, Europe, and Australia. BeiGene's key projects include the development of oncology therapies such as BRUKINSA® (zanubrutinib), tislelizumab, and pamiparib, targeting various cancers through precise molecular pathways and enhancing immune responses against tumors. These projects underscore BeiGene's commitment to advancing cancer treatment and improving patient outcomes on a global scale, maintaining a focus on both novel and in-licensed therapies.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai revenue untuk BeOne Medicines AG - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah 4,562.00 MM.
Nilai operating income untuk BeOne Medicines AG - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -101.51 MM.
Nilai net income untuk BeOne Medicines AG - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -177.64 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	4,562.00	-101.51	-177.64
2025-03-31	4,175.87	-296.56	-392.37
2024-12-31	3,810.24	-569.01	-644.79
2024-09-30	23,507.73	-6,218.22	-5,993.33
2024-06-30	3,096.53	-887.08	-523.70
2024-03-31	2,762.63	-1,098.64	-784.43
2023-12-31	2,458.78	-1,208.55	-881.71
2023-09-30	15,648.64	-9,290.15	-7,127.54
2023-06-30	1,810.79	-1,597.76	-1,732.46
2023-03-31	1,557.10	-1,718.45	-1,917.05
2022-12-31	1,415.92	-1,789.66	-2,003.82
2022-09-30	1,249.81	-1,894.34	-2,149.16
2022-06-30	1,068.62	-1,918.31	-2,029.72
2022-03-31	877.04	-1,953.74	-1,959.51
2021-12-31	1,176.28	-1,438.73	-1,457.82
2021-09-30	1,062.40	-1,351.91	-1,339.88
2021-06-30	947.04	-1,329.72	-1,326.99
2021-03-31	862.69	-1,213.76	-1,166.68
2020-12-31	308.87	-1,657.68	-1,624.97
2020-09-30	265.67	-1,560.81	-1,512.22

Laporan Laba Rugi: EPS

earnings per share basic untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -1.66.
laba per saham yang terdilusi untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -1.65.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30	-1.66	-1.65
2025-03-31	-3.70	-3.64
2024-12-31	-6.12
2024-09-30	-57.43	-57.43
2024-06-30	-5.01	-4.97
2024-03-31	-7.51	-7.57
2023-12-31	-8.45
2023-09-30	-68.24	-68.69
2023-06-30	-16.66	-16.66
2023-03-31	-18.51	-18.51
2022-12-31	-19.43
2022-09-30	-21.29	-21.28
2022-06-30	-20.65	-20.67
2022-03-31	-20.51	-20.47
2021-12-31	-15.71
2021-09-30	-14.60	-14.54
2021-06-30	-14.66	-14.64
2021-03-31	-13.41	-13.47
2020-12-31	-19.47
2020-09-30	-19.92	-19.92

Arus Kas: Operasi, Investasi, Pendanaan

Nilai cash from operating activities untuk BeOne Medicines AG - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah 571.21 MM.
Nilai cash from investing activities untuk BeOne Medicines AG - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -416.03 MM.
Nilai kas dari aktivitas pendanaan untuk BeOne Medicines AG - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah 9.39 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	571.21	-416.03	9.39
2025-03-31	212.02	-460.46	-2.62
2024-12-31	-140.63	-548.35	193.45
2024-09-30	-4,558.50	-4,599.64	3,863.42
2024-06-30	-703.95	-569.72	455.58
2024-03-31	-902.25	-390.89	598.64
2023-12-31	-1,157.45	60.00	416.48
2023-09-30	-7,723.30	3,104.43	-554.68
2023-06-30	-1,737.76	516.88	156.09
2023-03-31	-1,823.83	1,107.79	-27.57
2022-12-31	-1,496.62	1,077.12	-18.97
2022-09-30	-1,686.27	1,147.70	3,476.05
2022-06-30	-1,620.07	966.22	3,465.01
2022-03-31	-1,660.38	559.10	3,518.22
2021-12-31	-1,298.72	640.66	3,636.91
2021-09-30	-1,123.22	444.62	577.91
2021-06-30	-973.75	-1,079.96	2,462.72
2021-03-31	-816.42	-1,761.45	2,508.08
2020-12-31	-1,283.46	-3,168.37	5,202.83
2020-09-30	-1,218.31	-3,105.33	4,879.37

Metrik Penilaian: PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Efektivitas Manajemen

roa untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.07.
roe untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.12.
roic untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.09.
croic untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.06.
ocroic untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.05.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2025-06-30	-0.07	-0.12	-0.09	-0.06	0.05
2025-03-31	-0.11	-0.19	-0.15	-0.12	-0.03
2024-12-31	-0.11	-0.18	-0.15	-0.12	-0.03
2024-09-30	-1.08	-1.59	-0.57	-0.51	-0.43
2024-06-30	-0.13	-0.19	-0.18	-0.17	-0.20
2024-03-31	-0.14	-0.20	-0.20	-0.15	-0.26
2023-12-31	-0.14	-0.21	-0.22	-0.26	-0.29
2023-09-30	-0.23	-0.33	-0.35	-0.23	-0.35
2023-06-30	-0.23	-0.33	-0.35	-0.23	-0.35
2023-03-31	-0.24	-0.33	-0.41	-0.17	-0.39
2022-12-31	-0.40	-0.63	-0.36	0.48	-0.29
2022-09-30	-0.40	-0.63	-0.36	0.48	-0.29
2022-06-30	-0.36	-0.56	-0.32	0.44	-0.26
2022-03-31	-0.33	-0.48	-0.27	0.35	-0.24
2021-12-31	-0.25	-0.37	-0.19	0.41	-0.18
2021-09-30	-0.23	-0.30	-0.29	-0.02	-0.25
2021-06-30	-0.34	-0.52	-0.31	0.10	-0.23
2021-03-31	-0.29	-0.41	-0.25	-0.01	-0.18
2020-12-31	-0.99	-1.63	-0.34	0.16	-0.27
2020-09-30	-0.80	-1.17	-0.33	0.13	-0.27

Gross Margins

marjin kotor untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.85.
marjin bersih untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.09.
marjin operasi untuk BeOne Medicines AG - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.07.

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2025-06-30	0.85	-0.09	-0.07
2025-03-31	0.84	-0.17	-0.15
2024-12-31	0.84	-0.17	-0.15
2024-09-30	0.84	-0.25	-0.26
2024-06-30	0.79	-0.28	-0.40
2024-03-31	0.78	-0.36	-0.49
2023-12-31	0.06	-0.44	-0.59
2023-09-30	-0.12	-0.96	-0.88
2023-06-30	-0.12	-0.96	-0.88
2023-03-31	-0.26	-1.23	-1.10
2022-12-31	-0.51	-1.68	-1.52
2022-09-30	-0.51	-1.68	-1.52
2022-06-30	-0.67	-1.88	-1.80
2022-03-31	-0.97	-2.18	-2.23
2021-12-31	-0.38	-1.20	-1.22
2021-09-30	-0.43	-1.22	-1.27
2021-06-30	-0.58	-1.39	-1.40
2021-03-31	-0.62	-1.35	-1.41
2020-12-31	-3.42	-5.17	-5.37
2020-09-30	-3.86	-5.69	-5.88